About: The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2004 (fr) наукова стаття, опублікована в липні 2004 (uk) im Juli 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2004 (ast) scientific article published on 01 July 2004 (en)
publication date	wds:Q80356603-584F75AE-32DF-4E95-9F6D-2AC344A95557
publication date	2004-07-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q80356603-26B04395-335E-4DA1-9020-9405A7EC8E51 wds:Q80356603-5C2F1DC2-47EA-43EB-A574-8159E4AA1397 wds:Q80356603-67936FF6-3835-4A1C-9EA8-D7D1ED715F84 wds:Q80356603-76D20541-C8D5-4D30-9F0E-991F83B36AFF wds:Q80356603-A4A12F61-9EA6-42B0-BEAA-576E986E8950 wds:Q80356603-BC647EAD-FEF8-41FA-8982-C245B06C5B36 wds:Q80356603-CF6D1EE2-7493-4B06-912C-3480D540251C wds:Q80356603-D9AE9C90-6383-481F-A60F-3CE27B48440C wds:Q80356603-DCED6266-69FE-4592-902B-043E06F5598B
cites work	Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels Vascular endothelial growth factor serum concentrations in ovarian cancer. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer Angiogenesis in primary and metastatic epithelial ovarian carcinoma Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours
author name string	wds:Q80356603-0920504B-3284-449D-AC13-74B41C69FCE1 wds:Q80356603-128EB920-BF4B-4A69-9721-2A34A8EF45DC wds:Q80356603-1CFE8FB5-A27E-4898-BC8C-2A82DC1F07A3 wds:Q80356603-6E26B735-19FF-44D5-9443-AD3CC15AC7C5
author name string	Gustavo C Rodriguez Kimberly Blackwell Stacey A Snyder Robyn Sayer
rdfs:label	The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (en) The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (nl)
skos:prefLabel	The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (en) The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (nl)
name	The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (en) The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (nl)
author	wds:Q80356603-75747390-1A81-4403-BD0F-E5EF73A1B154 wds:Q80356603-784BC2CB-F1E1-44A3-B71D-453604A60EE2 wds:Q80356603-E5471D29-D6FF-4DA0-8076-488E3D5FEF6E
author	Andrew Berchuck Angeles Alvarez Secord Gloria Broadwater
title	wds:Q80356603-3B12B17D-6957-41BE-8BEE-E5A60C6E15A0
title	The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer (en)
page(s)	wds:Q80356603-8C8D44E5-44B0-4586-BC85-CF61272C0DF6
page(s)	74-79
instance of	wds:Q80356603-5779F034-EB09-430D-B831-D338AB6F5654
instance of	scholarly article
main subject	wds:Q80356603-C2E34B89-35C7-4319-88F2-2CFCADFB9055
main subject	ovarian neoplasm
PubMed ID	wds:Q80356603-D9BAAAEC-14F4-49EB-A12A-7493476EAE61
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15262122
PubMed ID	15262122
published in	wds:Q80356603-ED55DDB6-C5A1-46B7-85BF-62D836F88C3D
published in	Gynecologic Oncology
issue	wds:Q80356603-1ABE90CE-0942-43FB-B123-C934293E19FB
volume	wds:Q80356603-A748F8D7-7214-44F5-A8BB-B218E73716B9
issue	1
volume	94
DOI	wds:Q80356603-897DB6F4-211C-4A23-9E3D-CA66F5FAB8FF
DOI	http://dx.doi.org/10.1016/J.YGYNO.2004.03.043
DOI	10.1016/J.YGYNO.2004.03.043
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80356603
is cites work of	Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evalu Clinical biomarkers of angiogenesis inhibition Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherap The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer Vascular endothelial growth factor, persistent disease, and survival in ovarian cancer Maintenance immunotherapy in recurrent ovarian cancer: long term follow-up of a phase II study.
is cites work of	wds:Q33553922-B0E92E17-4E05-4B19-A1CB-3F000B50A607 wds:Q43195485-C0E3B619-0EC2-4228-8AE7-868B2FC59C26 wds:Q57904741-10B00018-100D-416B-9771-AEE3E3F57F1F wds:Q82427987-1C92B371-4F4A-4E6E-88CB-451699B89D4D wds:Q37139413-4E47C18A-D611-45B6-880B-14268DEBA7C5 wds:Q81121012-3E7C5A46-996F-42C2-8AB6-76D4FEFD12B4 wds:Q43251199-D5E7C0BB-17E9-4DE3-9C3B-9E7234B6A5E8 wds:Q42905560-5DE1B213-3DE3-483E-9DA2-08C0874EBDA2 wds:Q57306045-47BF67B1-3C76-4891-A910-2964D8760D20 wds:Q34557233-D379AF8A-A35E-4033-9E07-82A0CC4ADFE6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software